Carl Zeiss Meditec AG (AFX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carl Zeiss Meditec AG (AFX) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Carl Zeiss Meditec AG for the company's overall valuation and market capitalisation.
Carl Zeiss Meditec AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Carl Zeiss Meditec AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Carl Zeiss Meditec AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carl Zeiss Meditec AG ranked by their cash flow conversion efficiency. Explore Carl Zeiss Meditec AG (AFX) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Meitu Inc
F:M5U
|
0.013x |
|
Verallia
PA:VRLA
|
0.210x |
|
Kennametal Inc
NYSE:KMT
|
-0.002x |
|
Calumet Specialty Products Partners
NASDAQ:CLMT
|
-0.223x |
|
Beijing BDStar Navigation Co Ltd
SHE:002151
|
0.001x |
|
Petrokent Turizm AS
IS:PKENT
|
0.023x |
|
Bestechnic (Shanghai) Co. Ltd. A
SHG:688608
|
0.042x |
|
GavYam Lands Corp Ltd
TA:GVYM
|
0.019x |
Annual Cash Flow Conversion Efficiency for Carl Zeiss Meditec AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Carl Zeiss Meditec AG from 2014 to 2025. View AFX live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €2.13 Billion ≈ $2.49 Billion |
€209.86 Million ≈ $245.35 Million |
0.099x | -17.99% |
| 2024-09-30 | €2.06 Billion ≈ $2.40 Billion |
€247.32 Million ≈ $289.14 Million |
0.120x | +4.17% |
| 2023-09-30 | €2.17 Billion ≈ $2.54 Billion |
€250.86 Million ≈ $293.28 Million |
0.115x | +24.53% |
| 2022-09-30 | €2.03 Billion ≈ $2.37 Billion |
€188.20 Million ≈ $220.02 Million |
0.093x | -57.12% |
| 2021-09-30 | €1.68 Billion ≈ $1.96 Billion |
€362.66 Million ≈ $423.99 Million |
0.216x | +75.67% |
| 2020-09-30 | €1.45 Billion ≈ $1.70 Billion |
€178.53 Million ≈ $208.72 Million |
0.123x | -20.60% |
| 2019-09-30 | €1.42 Billion ≈ $1.66 Billion |
€219.63 Million ≈ $256.78 Million |
0.155x | +8.85% |
| 2018-09-30 | €1.31 Billion ≈ $1.54 Billion |
€187.21 Million ≈ $218.86 Million |
0.142x | +368.64% |
| 2017-09-30 | €1.24 Billion ≈ $1.45 Billion |
€37.73 Million ≈ $44.11 Million |
0.030x | -76.86% |
| 2016-09-30 | €851.16 Million ≈ $995.10 Million |
€111.77 Million ≈ $130.67 Million |
0.131x | +84.54% |
| 2015-09-30 | €797.45 Million ≈ $932.30 Million |
€56.74 Million ≈ $66.34 Million |
0.071x | -14.95% |
| 2014-09-30 | €754.23 Million ≈ $881.77 Million |
€63.10 Million ≈ $73.78 Million |
0.084x | -- |
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more